Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
351
-
Total 13F shares, excl. options
-
77,621,320
-
Shares change
-
+2,363,467
-
Total reported value, excl. options
-
$17,214,766,292
-
Value change
-
+$574,320,737
-
Put/Call ratio
-
75.29%
-
Number of buys
-
192
-
Number of sells
-
-151
-
Price
-
$221.82
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q2 2021
425 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q2 2021.
NovoCure Ltd - Common Stock (NVCR) has 351 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 77,621,320 shares
of 111,111,111 outstanding shares and own 69.86% of the company stock.
Largest 10 shareholders include Capital World Investors (11,845,701 shares), FMR LLC (9,619,134 shares), BAILLIE GIFFORD & CO (9,301,081 shares), Capital International Investors (9,143,742 shares), VANGUARD GROUP INC (7,809,123 shares), BlackRock Inc. (6,519,780 shares), STATE STREET CORP (2,248,585 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,569,485 shares), CREDIT SUISSE AG/ (1,269,504 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,195,015 shares).
This table shows the top 351 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.